E-LIB Suche - Ergebnisse für: Izutsu, Koji

1

Venetoclax treatment for chronic lymphocytic leukemia/small..:

Ito, Tomoki ; Kamimura, Tomohiko ; Kiguchi, Toru...
International Journal of Hematology. , 2024

2

First Data From Subcutaneous Epcoritamab + Polatuzumab Vedo..:

Kerr, Daniel Alan ; Lavie, David ; Avigdor, Abraham...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S217 , 2024

Link: https://doi.org/10.1016/..

3

TCL-391 Valemetostat Monotherapy in Patients With Relapsed/..:

Maruyama, Dai ; Porcu, Pierluigi ; Tobinai, Kensei...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S523-S524 , 2024

Link: https://doi.org/10.1016/..

4

Heterogeneity or change in cell of origin in diffuse large ..:

Maeshima, Akiko Miyagi ; Taniguchi, Hirokazu ; Takahashi, Yuka...
Human Pathology. 151 (2024) - p. 105630 , 2024

Link: https://doi.org/10.1016/..

5

ABCL-193 Impact of Bridging Therapy (BT) on Lisocabtagene M..:

Dahiya, Saurabh ; Hirayama, Alexandre V. ; Schuster, Stephen J....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S462-S463 , 2024

Link: https://doi.org/10.1016/..

6

The kappa/lambda ratio of surface immunoglobulin light chai..:

Aruga, Yu ; Ikeda, Chiaki ; Matsushita, Hiromichi...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

TCL-394 Valemetostat for Patients With R/R Peripheral T-Cel..:

Horwitz, Steven ; Izutsu, Koji ; Mehta-Shah, Neha...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S524-S525 , 2024

Link: https://doi.org/10.1016/..

8

Impact of Bridging Therapy (BT) on Lisocabtagene Maraleucel..:

Dahiya, Saurabh ; Hirayama, Alexandre V. ; Schuster, Stephen J....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S212 , 2024

Link: https://doi.org/10.1016/..

9

Valemetostat Monotherapy in Patients With Relapsed/Refracto..:

Maruyama, Dai ; Porcu, Pierluigi ; Tobinai, Kensei...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S229 , 2024

Link: https://doi.org/10.1016/..

10

Valemetostat for Patients With R/R Peripheral T-Cell Lympho..:

Horwitz, Steven ; Izutsu, Koji ; Mehta-Shah, Neha...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S155 , 2024

Link: https://doi.org/10.1016/..

11

Tazemetostat for relapsed/refractory B-cell non-Hodgkin lym..:

Izutsu, Koji ; Ando, Kiyoshi ; Nishikori, Momoko...
International Journal of Hematology. , 2024

Link: https://doi.org/10.1007/..

12

Glasdegib with intensive/nonintensive chemotherapy in Japan..:

Izutsu, Koji ; Ubukawa, Kumi ; Morishita, Takanobu...
Cancer Science. 115 (2024) 4 - p. 1250-1260 , 2024

Link: https://doi.org/10.1111/..

13

Clinicopathological differences between T-lymphoblastic leu..:

Takahashi, Yuka ; Kaimi, Yuto ; Taniguchi, Hirokazu...
Human Pathology. 150 (2024) - p. 78-85 , 2024

Link: https://doi.org/10.1016/..

14

Safety and efficacy of acalabrutinib and obinutuzumab in tr..:

Takizawa, Jun ; Teshima, Takanori ; Ennishi, Daisuke...
Leukemia & Lymphoma. , 2024

Link: https://doi.org/10.1080/..

15

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia:..:

Yamaguchi, Motoko ; Fukuhara, Noriko ; Takizawa, Jun...
Journal of Clinical and Experimental Hematopathology. , 2024

Link: https://doi.org/10.3960/..